Clinical Trial

A Study to Evaluate the Effect of Food on the Pharmacokinetic Characteristics and Safety Profile of KH607 in Healthy Chinese Participants

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated June 9, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is a randomized, open-label, 2-period, 2-sequence, crossover food-effect study designed to evaluate the effect of a high-fat meal on the pharmacokinetics of a single oral dose of KH607 tablets in healthy participants, as well as to assess the safety of a single oral dose of KH607 tablets administered under fasting and fed conditions in healthy participants.
Trial Details
NCT Number NCT07634874
Lead Sponsor Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Conditions Food Effect of KH607 in Chinese Health Participants
Enrollment 16 participants
Start Date 2026-06
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-06-09